Latest News for SHJBF
SHANGHAI, May 26, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that a randomized, double-blind, placebo-controlled, multi-center phase III clinical study (“NEOTORCH”, NCT04158440) of the company's product…
Results from early clinical studies across Junshi Biosciences' innovative pipeline were presented at the 2026 AACR, featuring: JS212 (EGFR/HER3 ADC), the J
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SHJBF.
Senate Trading
No Senate trades found for SHJBF.
U.S. House Trading
No House trades found for SHJBF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.